Pharmacokinetics and pharmacodynamics of furosemide after oral administration to horses

Journal of Veterinary Internal Medicine

Volumn 18, Issue 5, 2004, Pages 739-743

  Johansson, Anna M ^a   Gardner, Sarah Y ^a   Levine, Jay F ^a   Papich, Mark G ^a   LaFevers, D Heath ^a   Goldman, Rebecca B ^a   Sheets, M Katie ^a   Atkins, Clarke E ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Equine; Frusemide; Loop diuretic; Oral bioavailability

Indexed keywords

FUROSEMIDE; PLACEBO;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIURESIS; DIURETIC ACTIVITY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DETERMINATION; EXPERIMENTAL DESIGN; FEMALE; FLUORESCENCE; HORSE; NONHUMAN; RANDOMIZATION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SOLID; URINE; URINE VOLUME;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIURETICS; FEMALE; FUROSEMIDE; HORSES; INJECTIONS, INTRAVENOUS; SPECIFIC GRAVITY; TREATMENT OUTCOME;

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

EID: 6444225196     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2004)18<739:PAPOFA>2.0.CO;2     Document Type: Article

References (25)

1. Baggot JD. The pharmacological basis of cardiac drug selection for use in horses. Equine Vet J 1995;(Suppl):97-100.
2. Muir WW, McGuirk SM. Pharmacology and pharmacokinetics of drugs used to treat cardiac disease in horses. Vet Clin North Am Equine Pract 1985;1:335-352.
3. Vail CD, Beeman GM, Johnson HW. Furosemide in equine practice. Vet Med Small Anim Clin 1967;62:881-884.
4. Beech J. Miscellaneous lung and pleural injuries. In: Beech J, ed. Equine Respiratory Disease. Malvern, PA: Lea & Febiger; 1991:215-222.
5. Divers TJ, Whitlock RH, Byars TD, et al. Acute renal failure in six horses resulting from haemodynamic causes. Equine Vet J 1987;19:178-184.
6. Hinchcliff KW. Effects of furosemide on athletic performance and exercise-induced pulmonary hemorrhage in horses. J Am Vet Med Assoc 1999;215:630-635.
7. Soma LR, Uboh CE. Review of furosemide in horse racing: Its effects and regulation. J Vet Pharmacol Ther 1998;21:228-240.
8. Hoechst-Roussel-Vet. Lasix injection 5%. In: Arrioja-Dechert A, ed. Compendium of Veterinary Products. Port Huron, MI: North American Compendiums, Inc; 1999:1605-1606.
9. Hoechst-Roussel-Vet. Lasix tablets. In: Arrioja-Dechert A, ed. Compendium of Veterinary Products. Port Huron, MI: North American Compendiums, Inc; 1999:1607-1608.
10. Mogg TD. Equine cardiac disease. Clinical pharmacology and therapeutics. Vet Clin North Am Equine Pract 1999;15:523-534, vii.
11. Orsini JA, Kreuder C. Medication administration. In: Orsini JA, Divers TJ, eds. Manual of Equine Emergencies. Treatment & Procedures. Philadelphia, PA: WB Saunders Company; 1998:6-12.
12. Glantz SA. Experiments in which each subject recieves more than one treatment: The Friedman test. In: Glantz SA, ed. Primer of Biostatistics, 2nd ed. San Fransisco, CA: McGraw-Hill; 1985:317-322.
13. Johansson AM, Gardner SY, Levine JF, et al. Furosemide continuous rate infusion in the horse: Evaluation of enhanced efficacy and reduced side effects. J Vet Intern Med 2003;17:887-895.
14. Riviere JE. Compartmental models. In: Riviere JE, ed. Comparative Pharmacokinetics. Principles, Techniques, and Applications. Ames, IA: Iowa State University Press; 1999:107-147.
15. Riviere JE. Noncompartmental models. In: Riviere JE, ed. Comparative Pharmacokinetics. Principles, Techniques, and Applications. Ames, IA: Iowa State University Press; 1999:148-167.
16. Riviere JE. Bioavailability. In: Riviere JE, ed. Comparative Pharmacokinetics. Principles, Techniques, and Applications. Ames, IA: Iowa State University Press; 1999:43-45.
17. Noether GE. Introduction to statistics: The nonparametric way. New York, NY: Springer-Verlag; 1991.
18. Tobin T, Roberts BL, Swerczek TW, et al. The pharmacology of furosemide in the horse. III. Dose and time response relationships, effects of repeated dosing, and performance effects. J Equine Med Surg 1978;2:216-226.
19. Plumb DC. Veterinary Drug Handbook. White Bear Lake, MN: Pharma Vet Publishing; 1999;297-299.
20. Martin BK, Uihlein M, Ings RM, et al. Comparative bioavailability of two furosemide formulations in humans. J Pharm Sci 1984;73:437-441.
21. Grannen A, Hammarlund M, Lundqvist T. Implications of intraindividual variability in bioavailability studies of furosemide. Eur J Clin Pharmacol 1984;27:595-602.
22. Molz KH, Pabst G, Dilger C, et al. Multiple peaks and low bioavailability of furosemide correlate with the volume of fluid ingested. Eur J Drug Metab Pharmacokinet 1991;(Spec)3:194-200.
23. Kim EJ, Han KS, Lee MG. Gastrointestinal first-pass effect of furosemide in rats. J Pharm Pharmacol 2000;52:1337-1343.
24. Chay S, Woods WE, Rowse K, et al. The pharmacology of furosemide in the horse. V. Pharmacokinetics and blood levels of furosemide after intravenous administration. Drug Metab Dispos 1983;11:226-231.
25. Roberts BL, Blake JW, Tobin T. The pharmacology of furosemide in the horse. II. Its detection, pharmacokinetics, and clearance from urine. J Equine Med Surg 1978;2:185-194.